WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $69 million in its third quarter. On a per-share basis, the Waltham, Massachusetts-based ...

The October 2024 report from the Mecosta County Sheriff's Office for calls in Aetna, Austin and Big Rapids Charter townships ...

Three people have been charged in connection with the death of Liam Payne, a former member of musical group One Direction who ...

On Thursday, November 7, 80 candidates from 39 countries took the Oath of Allegiance in Storer Auditorium, officially ...

The S&P 500 is poised for continued growth into mid-2025 after Trump's victory: Evercore ISI The stock-market rally still has room to run, as Donald Trump's stunning comeback for the White House and a ...

Scott, who directed 'Blade Runner' and 'Gladiator,' compared himself to the 94-year-old Clint Eastwood 'Are you kidding? I wouldn't be doing it if it felt like work. It's my passion and therefore my ...

Aetna and OptumHealth agreed to settle a long-running class-action lawsuit over their administration of employee health ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Aetna Inc. and OptumHealth Care Solutions Inc. will settle a class action saying they wrongly conspired to charge patients ...

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...